Please login to the form below

Not currently logged in
Email:
Password:

Quantum Pharma promotes Chris Rigg to chief financial officer

He succeeds Martin Such in the role

Quantum Pharma Chris RiggsDurham, UK-based Quantum Pharma has promoted Chris Rigg from group strategic director to chief financial officer and board member following the resignation of Martin Such earlier this month.

Rigg joined the pharmaceutical manufacturer in November 2015 from NRG, a national recruitment agency, where he had served as chief executive officer since 2013.

He brings 20 years of financial and managerial experience to the role, having worked at Deloitte, Eaga, PriceWaterhouseCoopers and Barclays, where he headed up its North East corporate banking division.

Andrew Scaife, chief executive officer at Quantum, said: “We are delighted to welcome Chris to the board as chief financial officer.

“Chris has a wealth of relevant experience in management, finance and strategic matters and … a good understanding of the group's businesses.

“On behalf of the board I would like to extend sincere thanks to Martin Such for his significant contribution to the success and growth of the company during the past eight years and, in particular, to its listing in 2014.”

18th March 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics